Shenzhen Edge Medical Co (HKSE:02675) Piotroski F-Score: 5 (As of Aug. 14, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02675 Shenzhen Edge Medical Co Ltd HKSE:02675
11 GF Score
Price HK$38.30
! 3 Warning Signs
View Full Analysis

What is Shenzhen Edge Medical Co Piotroski F-Score?

Shenzhen Edge Medical Co HKSE:02675 -3.14% 11 Piotroski F-Score is 5 as of Aug. 14, 2026, which is at its 10-year median of 5.00. GuruFocus rates HKSE:02675 with a GF Score™ of 11/100. The stock has 3 warning signs investors should review. Among 799 Medical Devices & Instruments companies, Shenzhen Edge Medical Co ranks better than 65.21% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Shenzhen Edge Medical Co has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Shenzhen Edge Medical Co's Piotroski F-Score or its related term are showing as below:

HKSE:02675' s Piotroski F-Score Range Over the Past 10 Years
Min: 5   Med: 5   Max: 5
Current: 5

During the past 3 years, the highest Piotroski F-Score of Shenzhen Edge Medical Co was 5. The lowest was 5. And the median was 5.

Shenzhen Edge Medical Co  (HKSE:02675) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Shenzhen Edge Medical Co Piotroski F-Score Related Terms


Shenzhen Edge Medical Co Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Shenzhen Edge Medical Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shenzhen Edge Medical Co Piotroski F-Score Chart

Shenzhen Edge Medical Co Annual Data
Trend Dec23 Dec24 Dec25
Piotroski F-Score
N/A N/A 5.00

Shenzhen Edge Medical Co Semi-Annual Data
Dec23 Jun24 Dec24 Jun25 Dec25
Piotroski F-Score N/A 0.00 N/A 0.00 5.00

HKSE:02675 vs ABT, SYK, MDT: Piotroski F-Score Comparison

For the Medical Devices subindustry, Shenzhen Edge Medical Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen Edge Medical Co Piotroski F-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shenzhen Edge Medical Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Shenzhen Edge Medical Co's Piotroski F-Score falls into.


HKSE:02675
11GF Score
Shenzhen Edge Medical Co Ltd HKSE:02675
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Net Income was HK$-97.9 Mil.
Cash Flow from Operations was HK$-214.6 Mil.
Revenue was HK$503.4 Mil.
Gross Profit was HK$332.1 Mil.
Average Total Assets from the begining of this year (Dec24)
to the end of this year (Dec25) was (1452.813 + 1530.862) / 2 = HK$1491.8375 Mil.
Total Assets at the begining of this year (Dec24) was HK$1,452.8 Mil.
Long-Term Debt & Capital Lease Obligation was HK$6.2 Mil.
Total Current Assets was HK$1,474.1 Mil.
Total Current Liabilities was HK$181.7 Mil.
Net Income was HK$-233.3 Mil.

Revenue was HK$170.8 Mil.
Gross Profit was HK$104.7 Mil.
Average Total Assets from the begining of last year (Dec23)
to the end of last year (Dec24) was (1701.533 + 1452.813) / 2 = HK$1577.173 Mil.
Total Assets at the begining of last year (Dec23) was HK$1,701.5 Mil.
Long-Term Debt & Capital Lease Obligation was HK$11.0 Mil.
Total Current Assets was HK$1,350.4 Mil.
Total Current Liabilities was HK$92.7 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Shenzhen Edge Medical Co's current Net Income (TTM) was -97.9. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Shenzhen Edge Medical Co's current Cash Flow from Operations (TTM) was -214.6. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec24)
=-97.886/1452.813
=-0.06737688

ROA (Last Year)=Net Income/Total Assets (Dec23)
=-233.296/1701.533
=-0.1371093

Shenzhen Edge Medical Co's return on assets of this year was -0.06737688. Shenzhen Edge Medical Co's return on assets of last year was -0.1371093. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Shenzhen Edge Medical Co's current Net Income (TTM) was -97.9. Shenzhen Edge Medical Co's current Cash Flow from Operations (TTM) was -214.6. ==> -214.6 <= -97.9 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec24 to Dec25
=6.233/1491.8375
=0.00417807

Gearing (Last Year: Dec24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec23 to Dec24
=11.03/1577.173
=0.00699353

Shenzhen Edge Medical Co's gearing of this year was 0.00417807. Shenzhen Edge Medical Co's gearing of last year was 0.00699353. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec25)=Total Current Assets/Total Current Liabilities
=1474.091/181.667
=8.1142475

Current Ratio (Last Year: Dec24)=Total Current Assets/Total Current Liabilities
=1350.369/92.711
=14.56535902

Shenzhen Edge Medical Co's current ratio of this year was 8.1142475. Shenzhen Edge Medical Co's current ratio of last year was 14.56535902. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Shenzhen Edge Medical Co's number of shares in issue this year was 387.722. Shenzhen Edge Medical Co's number of shares in issue last year was 387.722. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=332.138/503.44
=0.65973701

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=104.714/170.821
=0.61300426

Shenzhen Edge Medical Co's gross margin of this year was 0.65973701. Shenzhen Edge Medical Co's gross margin of last year was 0.61300426. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec24)
=503.44/1452.813
=0.34652774

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec23)
=170.821/1701.533
=0.10039241

Shenzhen Edge Medical Co's asset turnover of this year was 0.34652774. Shenzhen Edge Medical Co's asset turnover of last year was 0.10039241. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+0+1+0+1+1+1
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Shenzhen Edge Medical Co has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 5 mean?
Shenzhen Edge Medical Co (HKSE:02675) has a Piotroski F-Score of 5 as of Aug. 14, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Shenzhen Edge Medical Co and its competitors. This is near median its historical median of 5.00. Over the past decade, Shenzhen Edge Medical Co's Piotroski F-Score has ranged from 5.00 to 5.00. According to the industry distribution chart, Shenzhen Edge Medical Co ranks #278 out of 799 companies in the Medical Devices & Instruments industry, placing it in the top 34.8%.
Is Shenzhen Edge Medical Co's Piotroski F-Score too high?
Shenzhen Edge Medical Co's current Piotroski F-Score of 5 is near median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 5.00 to a high of 5.00. The Medical Devices & Instruments industry median Piotroski F-Score is 5.00. Shenzhen Edge Medical Co's value of 5 is 0% at this industry median. Based on the distribution chart, Shenzhen Edge Medical Co ranks #278 out of 799 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Shenzhen Edge Medical Co has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Shenzhen Edge Medical Co's Piotroski F-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shenzhen Edge Medical Co ranks #278 out of 799 companies for Piotroski F-Score. This puts Shenzhen Edge Medical Co in the upper half of its industry. The industry median Piotroski F-Score is 5.00. Shenzhen Edge Medical Co's value of 5 is 0% at this benchmark. Historically, Shenzhen Edge Medical Co's own Piotroski F-Score has ranged from 5.00 to 5.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 5.00, Shenzhen Edge Medical Co has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Devices & Instruments company?
The median Piotroski F-Score among Medical Devices & Instruments companies is 5.00, based on 799 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shenzhen Edge Medical Co's current Piotroski F-Score of 5 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Shenzhen Edge Medical Co and its competitors. For the Medical Devices & Instruments industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shenzhen Edge Medical Co's current Piotroski F-Score is 5, which is near median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen Edge Medical Co stock overvalued right now?
Shenzhen Edge Medical Co (HKSE:02675) has a current Piotroski F-Score of 5. The current Piotroski F-Score is 5, which is near median its 10-year median of 5.00 and 0% at the Medical Devices & Instruments industry median of 5.00. Shenzhen Edge Medical Co's overall GF Score™ is 11/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Shenzhen Edge Medical Co (HKSE:02675), the current Piotroski F-Score is 5 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Shenzhen Edge Medical Co Business Description

Other Exchanges R5Z:Germany
Address Baolong Street, Room 1901, Building 2B, Smart Park Phase II, Longgang District, Shenzhen, CHN
Shenzhen Edge Medical Co Ltd is principally engaged in the designing, research and development, manufacturing and sale of surgical robots. It has a pipeline of three products and product candidates covering various models at different development stages to capture the market potential in surgical robots, including Edge Multi-Port Endoscopic Surgical Robot and Edge Single-Port Endoscopic Surgical Robot for MIS, as well as Edge Bronchoscope Robot for non-invasive surgery. The company derives revenue principally from the sales of surgical robot systems, instruments and accessories, and provision of services. Geographically, the maximum revenue is generated from the Chinese mainland, followed by Asia (other than Chinese Mainland), Europe, and Others.
11GF Score

Get the complete analysis for HKSE:02675

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$38.30
Price